Peptisource

Tirzepatid 60mg

Tirzepatid is a synthetic dual incretin receptor agonist that exerts pharmacological effects by activating GIPR and GLP-1R. Designed based on natural incretin molecules with amino acid modifications to optimize stability and efficacy, it is the first approved GIP/GLP-1 dual agonist, introducing innovative solutions for treating type 2 diabetes and obesity.

View COA
Spec: 60mg
Packaging: 1kits（10Vials）
$360USD
1

▎What is Tirzepatid？


Tirzepatid is a synthetic dual incretin receptor agonist that exerts pharmacological effects by activating GIPR and GLP-1R. Designed based on natural incretin molecules with amino acid modifications to optimize stability and efficacy, it is the first approved GIP/GLP-1 dual agonist, introducing innovative solutions for treating type 2 diabetes and obesity.